REVIEW PAPER
Periodontists’ perspective of HIV manifestations
 
More details
Hide details
 
Submission date: 2018-04-07
 
 
Acceptance date: 2018-04-19
 
 
Publication date: 2018-11-22
 
 
HIV & AIDS Review 2018;17(4):229-235
 
KEYWORDS
TOPICS
ABSTRACT
Human immunodeficiency virus (HIV) is a retrovirus having special affinity for the CD4 receptor molecule, which is present on the surface of T-helper lymphocytes. There are two genetically different but related forms of HIV, HIV-1 and HIV-2, that have been isolated from patients with acquired immunodeficiency syndrome (AIDS).
The development of periodontal disease in HIV patients is due to its host-microbial interaction. This results in a compromised host immune system leading to the destruction of periodontal supporting structures. The first clinical signs of HIV infection are often associated with various oral and perio-
dontal manifestations. HIV-associated periodontal lesions may be categorized as unusual forms of gingivitis, necrotizing periodontal diseases, and exacerbated periodontitis. These observations have led to the universal inclusion of almost all oral lesions in staging and classification schemes for HIV infection. In the last few decades, the dentists have played a paramount role in identifying and treating both common and uncommon oral and periodontal lesions in HIV-infected patients. This review aims to provide an update on the pathogenesis, re-activation of HIV, various periodontal manifestations of HIV, and recent updates on HIV management. An in depth understanding of AIDS and its oral manifestations is important for appropriate management of oral lesions in patients infected with HIV.
 
REFERENCES (58)
1.
Kumar V, Abbas A, Fausto N. Robbins and Cotran Pathologic Basis of Disease, 7th Edition. Elsevier. 2005.
 
2.
Uppoor AS, Nayak DG. HIV and Periodontal Disease: Redemption or Resurrection. J AIDS Clinic Res 2012; 3: 168.
 
3.
Padian NS, Shiboski SC, Glass SO, et al. Heterosexual transmission of human immune-deficiency virus in Northern California: results from a ten-year study. Am J Epidemiol 1997; 146: 350-357.
 
4.
Rees TD. Pathology and Management of Periodontal Problems in Patients with Human Immunodeficiency Virus Infection. In: Carranza’s Clinical Periodontology, pp. 174-183; doi: 10.1016/B978-1-4377-0416-7.00019-6.
 
5.
WHO. Global Health Observatory (GHO) data, HIV/AIDS, WHO 2018.
 
6.
National Guidelines for HIV Testing, National AIDS Control Organization (NACO), India 2015.
 
7.
Thomson MM, Najera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 2005; 7: 210-224.
 
8.
Lamster IB, Grbic JT, Buckland RS, et al. Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 1997; 3: S141-148.
 
9.
Coogan MM, Greenspan J, Challacombe SJ. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005; 83: 700-706.
 
10.
Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368: 489-504.
 
11.
Hunt PW, Carrington M. Host genetic determinants of HIV pathogenesis: an immunologic perspective. Curr Opin HIV AIDS 2008; 3: 342-348.
 
12.
González OA, Ebersole JL, Huang CB. Oral infectious diseases: A potential risk factor for HIV virus recrudescence? Oral Dis 2009; 15: 313-327.
 
13.
Folks TM, Clouse KA, Justement J, et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989; 86: 2365-2368.
 
14.
Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384: 529-534.
 
15.
Wang FX, Xu Y, Sullivan J, et al. IL-7 is a potent and pro-viral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 2005; 115: 128-137.
 
16.
Dennison DK, Smith B, Newland JR. Immune responsiveness and ANUG. J Dental Res 1985; 64 (Spec. Issue, abstr. no. 204).
 
17.
Narani N, Epstein JB. Classifications of oral lesions in HIV infection. J Clin Periodontol 2001; 28: 137-145.
 
18.
EEC-Clearinghouse on oral problems related to HIV infection and WHO collaborating center on oral manifestations of the human immunodeficiency virus. An update of the classification and diagnostic criteria of oral lesions in HIV-infection. J Oral Pathol Med 1991; 20: 97-100.
 
19.
Winkler JR, Robertson PB. Periodontal disease associated with HIV-infection. Oral Surg Oral Med Oral Pathol 1992; 73: 145-150.
 
20.
Holmstrup P, Westergaard J. Periodontal diseases in HIV-infected patients. J Clin Periodontol 1994; 21: 270-280.
 
21.
Genco RJ. Classification and clinical and radiographic features of periodontal diseases. In: Contemporary Periodontics. Genco RJ, Goldman FM, Cohen DW (eds.). CV Mosby Company, St. Louis 1990; pp. 63-81.
 
22.
Winkler JR, Grassi M, Murray PA. Clinical description and etiology of HIV-associated periodontal disease. In: Oral manifestations of AIDS. Proceedings of 1st International Symposium on Oral manifestations of AIDS. Robertson PB, Greenspan JS (eds.). PSG Publishing Company, Littleton 1988; pp. 49-70.
 
23.
Murray PA, Winkler JR, Peros WJ, et al. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions. Oral Microbiol Immunol 1991; 6: 34-40.
 
24.
EEC-Clearinghouse on Oral Problems Related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-291.
 
25.
Oral Health Care for People with HIV Infection. AIDS Institute, NY Department of Health, 2001; pp. 31-32.
 
26.
Armitage GC. Development of a Classification System for Periodontal Diseases and Conditions. University of California, 1994.
 
27.
Umadevi M, Adeyemi O, Patel M, et al. Periodontal diseases and other bacterial infections. Adv Dent Res 2006; 19: 139-145.
 
28.
Glossary of periodontal terms American Academy of Periodontology (AAP), 2018.
 
29.
Pindborg JJ, Holmstrup P. Necrotizing gingivitis related to Human Immunodeficiency Virus (HIV) infection. African Dental Journal 1987; 5-8.
 
30.
Riley C, London JP, Burmeister JA. Periodontal health in 200 HIV-positive patients. J Oral Pathol Med 1992; 21: 124-127.
 
31.
Murayama Y, Kurihara H, Nagai A, et al. Acute necrotizing ulcerative gingivitis: risk factors involving host defense mechanisms. Periodontol 2000 1994; 6: 116-124.
 
32.
Collet-Schaub D. The prevalence of acute necrotizing ulcerative gingivitis in Swiss military collectives [in German]. Schweiz Monatsschr Zahnmed 2000; 110: 538-541.
 
33.
Dean HT, Singleton Jr DE. Vincent’s infection – a wartime disease: preliminary considerations on the epidemiology of ulcerative gingivostomatitis. Am J Public Health 1945; 35: 433-440.
 
34.
Reichart PA, Geiderbiom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV-infection; virology, etiology, origin, immunology, precautions and clinical observations in 110 patients. Int J Oral Maxillofac Surg 1987; 16: 129-153.
 
35.
Schulten EJ, ten Kate RW, van der Waal I. Oral manifestations of HIV-infection in 75 Dutch patients. J Oral Pathol Med 1989; 18: 42-46.
 
36.
Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J Clin Periodontol 1992; 19: 794-801.
 
37.
Melnick SL, Engel D, Truelove E, et al. Oral mucosal lesions; Association with the presence of antibodies to the human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1989; 68: 37-43.
 
38.
Dufty J, Gkranias N, Nikos D. Necrotizing Ulcerative Gingivitis: A Literature Review. Oral Health Prev Dent 2017; 15: 321-327.
 
39.
Schiødt M, Pindborg JJ. AIDS and the oral cavity. Epidemiology and clinical oral manifestations of human immune deficiency virus infection: a review. Int J Oral Maxillofac Surg 1987; 16: 1-14.
 
40.
Schwartz O, Pindborg JJ, Svenningsen A. Tooth exfoliation and necrosis of the alveolar bone following trigeminal herpes zoster in HIV-infected patient. Danish Dental J 1989; 93: 701-710.
 
41.
Friedman RB, Gunsolley J, Gentry A, et al. Periodontal status of HIV-seropositive and AIDS patients. J Periodontol 1992; 62: 623-627.
 
42.
Reichart PA, Gelderblom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV-infection: virology, etiology, origin, immunology, precautions, and clinical observations in 110 patients. Int J Oral Maxillofac Surg 1987; 16: 129-153.
 
43.
Lucht E, Heimdah IA, Nord CE. Periodontal disease in HIV-infected patients in relation of lymphocyte subsets and specific micro-organisms. J Clin Periodontol 1991; 18: 252-256.
 
44.
Persson RE, Lars G, Hollender G, Rutger Persson G. Alveolar bone levels in AIDS and HIV seropositive patients and in control subjects. J Periodontol 1998; 69: 1056-1061.
 
45.
Murray PA, Grassi M, Winkler JR. The microbiology of HIV-associated periodontal lesions. J Clin Periodontol 1989; 16: 636-642.
 
46.
Murray PA, Winkler JR, Sadkowski L, et al. The microbiology of HIV-associated gingivitis and periodontitis. In: Robertson PB, Greenspan JS, eds. Perspectives on Oral Management of AIDS. PSG Publication Company Inc., Littleton 1988; 105-118.
 
47.
Masouredis CM, Katz MH, Greenspan D, et al. Prevalence of HIV-associated periodontitis and gingivitis in HIV-infected patients attending an AIDS clinic. J Acquir Immune Defic Syndr 1992; 5: 479-483.
 
48.
Phiri R, Feller L, Blignaut E. The severity, extent and recurrence of necrotizing periodontal disease in relation to HIV status and CD4+ T cell count. J Int Acad Periodontol 2010; 12: 98-103.
 
49.
Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994; 65: 393-397.
 
50.
Lamster IB, Grbic JT, Mitchell-Lewis DA, et al. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 1998; 3: 62-75.
 
51.
Ryder MI, Winkler JR, Weinreb RN. Elevated phagocytosis, oxidation burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Syndr 1988; 1: 346-53.
 
52.
An update on HIV and Periodontal disease – An AAP State of the art review, Mark Ryder 2002.
 
53.
Murray, Grassy, Winkler, Williams. Management of HIV associated periodontal diseases. 1988.
 
54.
Robinson PG. Treatment of HIV-associated periodontal diseases. Oral Dis 1997; 3: S238-240.
 
55.
Ryder MI, Nittayananta W, Coogan M, et al. Periodontal disease in HIV/AIDS. Periodontol 2000 2012; 60: 78-97.
 
56.
Pistorius A, Willershausen B. Cases of HIV-associated characteristic periodontal diseases. Eur J Med Res 1999; 4: 121-125.
 
57.
Sardi JC, Almeida AM, Mendes Giannini MJ. New antimicrobial therapies used against fungi present in subgingival sites – a brief review. Arch Oral Biol 2011; 56: 951-959.
 
58.
Consolidated WHO guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2016.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top